McCullough buddy is Endotoxin Induced Myocarditis expert
Dr Kirk Milhoan, a Pediatric Cardiologist kindly told the world that his 1991 PhD thesis was all about Endotoxin Heart Damage.
Let’s take a look at some of Kirk Milhoan’s contributions to Endotoxin Science.
In the picture below he was, in 2022, telling the world what Covid19 Jabs would do to young hearts, nicely translated into Chinese.
I think I recognize the lady sitting next to him.
Here is Kirk Milhoan on 28 May 2025 replying to me on X about his PhD on Endotoxin Induced Myocarditis.
I pointed out that his recent publication1 with The Wellness Company Peter A McCullough (Trademark)2 and others associated with its marketing push, failed to mention the definitive 2003 paper by Wong et al3 on Endotoxin epigenetics relating to its Induced Myocarditis.
Don’t you find it fascinating that the 6 authors selected 341 publications on Myocarditis and failed to mention the words Endotoxin or its equivalent Lipopolysaccharide, abbreviated LPS in their text.
Indeed the titles of the 314 selected papers do not mention the Heart supertoxin once, but I spotted reference 244 by Ilja Kruglikov et al.4
This is exceptionally interesting because Endotoxin Expert Iljab Kruglikov has published with Texan Endotoxin Expert Philipp Scherer of the University of Texas Southwestern Medical Center, Dallas.5
Some quotes from Kruglikov and Scherer in February 2021.
Several clinical reports demonstrate significantly increased levels of endotoxins in the plasma of severely affected COVID-19 patients.
LPS (Endotoxin) levels were investigated in a prospective study on 19 patients with severe pulmonary forms of COVID-19; almost 90% of them had increased LPS levels—40% demonstrated high and 30% demonstrated very high endotoxin levels [9].
Application of mendelian randomization using 6,492 hospitalized cases and over 1 million controls demonstrated that serum LBP levels strongly correlate with the hospitalization rate of COVID-19 patients [10].
The plasma levels of LBP were also investigated in 39 hospitalized patients with severe COVID-19 with significant cardiac pathology; these levels were initially high and remained high during hospitalization [11].
The paper by Wellness Company Mead et al. could not be published in a reputable journal so The Wellness Company created is own journal called Reseapro International Journal of Cardiovascular Research and Innovation.
Let’s look at this journal that chose Mead et al. as its very first publication.
Editor in Chief
Peter A. McCullough (Trademark)
Editors
Nils A. Guttenplan
Juan J. Velasco
Bronson Benno Joseph Raja
Bleri Celmeta
Benjamin Seadler
John A. St. Cyr
Mark Crompton
Hussain Haider Shah
Emmanuel D. Williams
Daniel L. Beckles
Sherin Saheera
Susy Kotit
Mladen J. Kocica
Abhinav Aggarwal
Jalles Dantas de Lucena
Ujjalkumar Subhash Das
Nukavarapu Raja Ramesh
Peter A. McCullough (Trademark)
Kirk Milhoan papers of interest
Dr Milhoan is currently located at Pediatric Cardiology, For Hearts and Souls, Ovilla, Texas.
He mentioned his 1991 thesis, and soon after in 1992 he published his study6 of endothelial cell associated Platelet-Activating Factor (PAF) and Hypoxia, which I have mentioned is involved in Endotoxin VITT.7
Dr Milhoan worked at Pediatric Cardiology, Children’s Hospital San Diego.
His coauthor Thomas A Lane is also an expert in Endotoxin.
To avoid exceeding email length limit, I will just attach references for subscribers who might want to delve further.
In 2010 he published a case study of Fetal Intrapericardial Teratoma.8 Teratoma has been linked to Endotoxin.91011
Dr Milhoan has participated with a number of people in press conferences and testimony to Covid19 hearings 12
Jessica Rose study shows Massive Myocarditis in 2003
Here is a slide produced by one of the Mead et al. authors, Jessica Rose, who has done some great deep dives into the US VAERS system. Her figure shows Myocarditis reports, normalized to reports per 100,000 Adverse Events.
Note the spike in 2003, the same year that Wong et al. published their Endotoxin Induced Myocarditis paper.
Jessica is fully aware of the Endotoxin in all Jabs.
I co-signed a letter with Mark Nathaniel Mead
As my friend Damon always says, it is a good idea to disclose related activity.
In March 2025, I was invited to sign an open letter13 to Canadian Health Authorities calling for in immediate halt to the use of and a recall of the COVID-19 mRNA vaccine products. Mark Nathaniel Mead and other TWC associates also signed that letter.
I have communicated directly with epidemiologict Dr Mead and asked him publicly why no relevant Endotoxin papers are listed in his Myocarditis or other Covid19 papers. He stated that the editors had removed much material.
Mead’s paper in Cureus14 was famously published and then later retracted by the journal.
Mead’s co-author Jessica Rose was very upset by the Cureus retraction, but despite repeated requests from her followers in social media, she refused to publish the list of reasons why the paper was pulled.
Mead and his co-authors failed to mention Endotoxin in their other publications.1516
I hope that Kirk Milhoan might influence their literature search and scientific understanding of Cytokine Storm before they publish any more papers.
M. Nathaniel Mead, Jessica Rose, William Makis, Kirk Milhoan, Nicolas Hulscher and Peter A. McCullough. 2025. Myocarditis after SARS-CoV-2 infection and COVID-19 vaccination: Epidemiology, outcomes, and new perspectives. Int. J. Cardiovasc. Res. Innov., 2025(1)-43.
Kruglikov IL, Shah M, Scherer PE. Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral–bacterial interactions. Elife. 2020;9:e61330. https://doi.org/10.7554/eLife.61330
Ilja L. Kruglikov, Philipp E. Scherer. Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes. February 2021. PLoS Pathog 17(2): e1009306. https://doi.org/10.1371/journal.ppat.1009306
KIRK A. MILHOAN, THOMAS A. LANE AND COLIN M. BLOOR. 1992. Hypoxia induces endothelial cells to increase their adherence for neutrophils: role of PAF Am. J. Physiol. 263 (Heart Circ. Physiol. 32):H956-H962.
Angela M. Fagiana, Shari Barnett, V. Sreenath Reddy and Kirk A. Milhoan. 2010. Management of a Fetal Intrapericardial Teratoma: A Case Report and Review of the Literature. Congenit Heart Dis. 2010;5:51–55
11 May 2022 press conference of the Global COVID Summit, featuring presentations by Dr. Ryan Cole, Dr. Lynn Fynn, Dr. Robert Malone, Dr. Richard Urso, Dr. Harvey Risch, Dr. Brian Tyson, Dr. Peter McCullough, Dr. Kirk Milhoan, Dr. David Wiseman, Dr. Mary Talley Bowden, Dr. Fady Hannah-Shmouni and Dr. Michael Yeadon. A recording of the press conference and a written declaration entitled “Declaration IV – Restore Scientific Integrity” can be found at https://globalcovidsummit.org/news/declaration-iv-restore-scientific-integrity
Call To Halt. Moncton, New Brunswick, Canada. 31 Mar 2025.M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, Russ Wolfinger, Nicolas Hulscher and Peter A. McCullough.
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, Jessica Rose, Kris Denhaerynck , Steve Kirsch and Peter A. McCullough. COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign. Cureus. 24 January 2024;16(1):e52876.
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, Jessica Rose, Kris Denhaerynck, Steve Kirsch and Peter A. McCullough. June 2024. COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1. International Journal of Vaccine Theory, Practice, and Research 3(1):1112-1178.
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, Russ Wolfinger, Nicolas Hulscher and Peter A. McCullough. August 2024. COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2. International Journal of Vaccine Theory, Practice, and Research 3(2):1275-1344.
I have to say Geoff ,
that the medical community whether research or clinical, is being extremely coy about Endotoxin.
Possibly because they want to argue that the MRNA platform just needs a little tweak here and there to become the next greatest invention, since the introduction of sliced bread.
And as Endotoxin contamination plagues any genetic platform at scale/i.e. grown in E.Coli, it has become the elephant in the room.
And they are also coy about the fact that antibiotic resistance is an absolute requirement of the process of manufacturing MRNA.
So two large elephants, that they are sure the public won't notice.
Here's a link to an online conference, where Resia Pretorius, in her presentation points out that research from 2011 shows that endotoxin causes fibrin in blood to misfold and become amyloid leading to amyloid clot formation. I thought of you when she said it.
https://open.substack.com/pub/philipmcmillan/p/hidden-drivers-of-post-covid-dysfunction?r=rr2sr&utm_campaign=post&utm_medium=web&showWelcomeOnShare=false
So it's the endotoxins in the MRNA injections that are leading to the amyloid/calamari clots. (My inference. Resia doesn't go there.)
Very good article.
I'm not qualified to debate the science at your level(theirs apparently too) but for me your hypothesis strengthens more from the co-incidences and the censorship of your message then the science anyway.
Perhaps behaviour rarely lie but clusters never do and we have clusters of behaviours and copious co-incidences that are racking up.